Adam J Sullivan (@SullivanStats) profile picture

Senior Director, Head of Biostatistics, Capricor Therapeutics, Inc. PhD in Biostatistics, Harvard University (2015)

Fredonia, NY
Joined July 2015
Photo by Adam J Sullivan (@SullivanStats)Photo by Adam J Sullivan (@SullivanStats)Photo by Adam J Sullivan (@SullivanStats)Photo by Adam J Sullivan (@SullivanStats)Photo by Adam J Sullivan (@SullivanStats)Photo by Adam J Sullivan (@SullivanStats)Photo by Adam J Sullivan (@SullivanStats)Photo by Adam J Sullivan (@SullivanStats)Photo by Adam J Sullivan (@SullivanStats)Photo by Adam J Sullivan (@SullivanStats)
Not sure why I keep flying @americanair. Seems like all I get is delays. Second time this week stuck in Chicago. Find another airline to level up this one is a mess.
2
2
1,451
Adam J Sullivan retweeted
Today at 1:00 p.m. ET, Capricor and @PPMD are hosting a webinar on the latest HOPE-3 open-label extension 2-year results, presented last week at the World Muscle Society Congress in Japan. We will walk through the data in more detail and discuss what these results may mean for the Duchenne muscular dystrophy community. Register here: bit.ly/3Ubm3c8 $CAPR #Deramiocel #PPMD #Duchenne #DMD
2
6
45
2,220
Adam J Sullivan retweeted
Capricor today announced new 24-month data from the HOPE-3 open-label extension, presented last week in a late-breaking poster at the 2026 World Muscle Society Congress in Hiroshima, Japan. Patients who began Deramiocel after a year on placebo experienced a 76% reduction in their rate of upper limb decline compared with their own prior year. At 24 months, both treatment groups had declined less than natural history predicts. Read the full press release: bit.ly/4ANTtOD #Duchenne #DMD #WMS2026 #Deramiocel $CAPR
5
11
60
3,020
Adam J Sullivan retweeted
New $CAPR 24-month OLE data released. What’s so striking to me is what happened when the placebo group crossed over to deramiocel: their rate of upper-limb decline slowed by 76%, from −2.05 PUL 2.0 points during their year on placebo to −0.49 during their first year on treatment. One of the strongest supportive signals that a drug is having an effect is when the same patients show a meaningful change after switching from placebo to treatment. This data further strengthens my belief that DMD patients need access immediately. capricor.com/investors/news-…
7
15
3
95
3,671
Adam J Sullivan retweeted
Late Breaking clinical trial #HOPE-3 OLE shows striking benefits of #deramiocel sustained over two years of therapy, and 76% slowing of #Duchenne myopathy progression in those who crossed over from placebo to deramiocel after one year. Work of ace #DMD trialist Craig McDonald highlighted at the @WorldMuscleSoc meeting in Hiroshima. Trial sponsored by @Capricor based on intellectual property from my team at Cedars-Sinai.
7
12
3
103
3,835
Adam J Sullivan retweeted
Capricor is headed to the 2026 World Muscle Society Congress in Hiroshima, Japan, September 29 – October 3. We’re looking forward to sharing new HOPE-3 open-label extension data for Deramiocel in Duchenne muscular dystrophy, including skeletal muscle and cardiac outcomes through 24 months. Dr. Craig McDonald of UC Davis will present the findings in a late-breaking poster and an oral presentation, alongside additional research from our StealthX™ platform exploring muscle-targeting extracellular vesicle technologies. We’re proud to continue advancing the science and working toward better options for boys and families living with Duchenne. 💙 Read more: bit.ly/3TFiBWZ $CAPR #Deramiocel #Duchenne #DMD #exosomes #WMS2026 #WorldMuscleSociety
9
1
64
2,211
Adam J Sullivan retweeted
Today, we join the global community in recognizing World Duchenne Awareness Day. This year’s theme, “Access Changes Lives,” reminds us that meaningful progress goes beyond just scientific breakthroughs. It means ensuring that individuals living with Duchenne and Becker muscular dystrophy have access to the care, support, and opportunities they need. At Capricor, we remain committed to continuing to push forward with Deramiocel and our mission to help make a difference in the lives of those living with DMD. Together, we can raise awareness, inspire action, and work toward a brighter future for the Duchenne community. 💚 $CAPR #WDAD2026 #DuchenneAwareness #DMD #AccessChangesLives #Deramiocel
5
6
56
1,760
Adam J Sullivan retweeted
Capricor has shared its comments regarding the FDA briefing materials in advance of the upcoming July 29 FDA Advisory Committee Meeting for Deramiocel. $CAPR #deramiocel #DMD Click the link below to read the press release.>>> bit.ly/4vRqq96
7
4
2
25
8,752
Same it’s been silence and they are behind on fulfilling the medication for me as well. I have sent several messages, emails and phone calls.
2
1
1
109
Be careful flying out of @AirportSioux with @AmericanAir and @envoyairr. Their flight had a mechanical issue that caused a delay on top of an original air traffic delay. They only claiming the ATC so they refuse vouchers. Fly @united or @delta instead
4
110
Replying to @WhitneyGrenaway
To me the most important thing is that you stayed consistent even with a horrible day! Praying for you! With everything going on in your life right now you are absolutely killing it!!!
1
16
Congratulations and Very well earned !!!
We are thrilled to report that Ani Eloyan, who joined our faculty in 2015, has been promoted to Associate Professor of Biostatistics, with tenure effective July 1, 2023! Check out our website for more information on Ani: brown.edu/academics/public-h…
7
480
Replying to @Brown_Epi
Congratulations Dr. Yorlets!!! Very proud of you!!!
133
Replying to @jwhogan42
Definitely not distracting but a very disturbing ethical structure that he adheres to.
37
Check out this new paper in JAMA Neurology with Brown Biostats’ Dr. Constantine Gatsonis!
Racial and Ethnic Differences in Amyloid PET Positivity in Individuals with Mild Cognitive Impairment or Dementia. Findings may reflect different etiology. https://xitter.cf/t.co/TqyW2Khq85 @DrCHWilkins @charles_windon @Brownbiostats @hillcv17 @Prof_R_Whitmer @DrMariaALZ @RabLab_UCSF
1
3
Thanks for the reminder. Currently on the list at like 131k.
1
1
"Along Your Career Path in Statistics and Data Science: Changing Careers" Free 10/14 webinar from the American Statistical Association Committee on Career Development community.amstat.org/ccd/eve… @ThisisStats @AmstatNews
Congratulations Ani!!!!
This Post is from an account that no longer exists. Learn more
2